MMJ Recs

JANUARY 25, 2022

So now that medical marijuana is finally available in Ohio, how do you get an Ohio MMJ card in 2022? Not all doctors in Ohio are certified to recommend medical marijuana treatment. How Do I Get My Ohio MMJ Card In 2022? What Are The Qualifying Conditions For A Medical Card In Ohio In 2022? Read on to find out!

Dispensary 52

Dispensary Chronic Pain Programs Treatment 52

Cannabis Law Report

FEBRUARY 14, 2022

Our families and communities are suffering, and we urgently need access to preventative and curative medicines and medical care that is safe and effective. These ground-breaking treatments offer therapeutic access to either psilocybin (the active ingredient in ‘magic mushrooms’) or MDMA, a synthetic medicine.

Medicine 52

Medicine Access Therapy Treatment 52

MMJ Recs

FEBRUARY 4, 2022

You can access all the MMJ products you need in the Sooner State’s many dispensaries using your OK MMJ card. If you’ve decided that this is the year you want to start using MMJ to alleviate your symptoms, read on for more information on how to get your Oklahoma MMJ card in 2022. The post How Do I Get My Oklahoma MMJ Card In 2022?

Conditions 52

Conditions Treatment Edibles Patients 52

Cannabis Law Report

MAY 18, 2022

Wednesday 18 May 2022. The session will examine how scientific evidence informs the policy and legislative framework used to control access to drugs in the UK. It will consider the potential harms and benefits of controlled drugs, and the treatments available for drug addiction and whether they are adequate. Inquiry: Drugs.

Policy 52

Policy Treatment Legislation Access 52

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Minnesota Rep. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

JULY 13, 2022

Here’s what they posted 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. Compliance Priority. Deter and address the unlawful import, advertising and supply of unapproved therapeutic goods associated with COVID-19.

Compliance 52

Compliance Compliance Wellness and Beauty Vaping 52

Cannabis Law Report

SEPTEMBER 1, 2022

UK medical cannabis charity, Sapphire Medical Foundation, has secured new funding to support access to prescriptions during the cost-of-living crisis. . From Wednesday 31 August, UK and Channel Island residents can apply for a grant to fully support their medical cannabis prescription, in the second grant round of 2022.

Treatment 52

Treatment Chronic Pain Access Patients 52

Cannabis Law Report

DECEMBER 21, 2021

This UK-based company caught our attention in 2021 for its team of renowned psychedelic researchers, including chief research officer Professor David Nutt, chief medical officer Dr. Ben Sessa, and head of ketamine psychotherapy Dr. Celia Morgan, as well as its unique studies into ketamine treatment for addiction and gambling addiction.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

TheAnswerPage

MAY 18, 2022

Epidiolex is an FDA-approved oral CBD solution indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in one year of age and older. link] Accessed April 30, 2020. Can it be prescribed for indications other than these three seizure disorders (i.e.

Pharmaceutical 52

Pharmaceutical Treatment Access CBD 52

TheAnswerPage

MAY 16, 2022

The effect of epidiolex (cannabidiol) on serum levels of concomitant anti-epileptic drugs in children and young adults with treatment-resistant epilepsy in an expanded access program. Friedman D, Cilio MR, Tilton N, et al. Presented at the annual meeting of the American Epilepsy Society, Seattle, December 5–9, 2014; abstract.

Epilepsy 52

Epilepsy Programs Treatment CBD 52

The Cannigma

JULY 12, 2022

Roll out of the program has been slow, and as of June 2022, there were still no doctors certified to issue prescriptions, no licensed dispensaries, and no legal farming of cannabis products. Unlike other states, Alabama requires doctors to document a failure of conventional medical treatment before issuing a medical cannabis prescription.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

Illinois News Joint

FEBRUARY 8, 2023

With a philosophy rooted in trauma-informed care, they believe in client-led healing and strive to truly listen and collaborate with patients to create individualized treatment plans that meet unique needs and lifestyles. One of our main goals is to increase the accessibility and affordability of medical cannabis as a treatment.”

Patients 84

Patients Treatment Environment Conditions 84

Cannabis Law Report

JULY 21, 2022

London, UK July 19, 2022. COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2022.

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

Cannabis Law Report

JANUARY 20, 2022

19 January 2022. Emergency access to restricted drugs has been restored by recent regulatory amendments to Health Canada’s Special Access Program (SAP). SAP allows health care professionals to request access to non-marketed drugs and medical devices not yet authorized for sale in Canada, on behalf of a patient.

Access 52

Access Programs Treatment Therapy 52

Cannabis Law Report

APRIL 21, 2022

Apr 20, 2022. NEW ORLEANS , April 20, 2022 /PRNewswire/ — Gary Hess , the founder and CEO of the Veterans Alliance for Holistic Alternatives (VAHA), announced today that four groundbreaking physicians are joining the VAHA Medical Advisory Board. “The patient is our textbook. “The patient is our textbook.

Therapy 52

Therapy Education Treatment Patients 52

MMJ Recs

JANUARY 20, 2024

Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment! The state’s thoughtful approach seeks to ensure that those with genuine medical needs have access to this alternative treatment while maintaining a balance between patient care and preventing misuse.

Law 52

Law Marijuana Patients Chronic Pain 52

MedicalJane

OCTOBER 28, 2022

during the forecast period (2022–2028), reaching a value of $40 billion by 2028. 37 states and the District of Columbia have legalized marijuana usage for medical purposes as of April 2022. A new report published by The Insight Partners shows that the global medical marijuana market is expected to grow at a CAGR of 19.2%

Chronic Pain 86

Chronic Pain Marijuana Medicine Pharmaceutical 86

Cannabis Law Report

MAY 16, 2022

MAY 16, 2022 BY DEANNA J. Gavin Newsom introduced proposed revisions to his 2022-2023 budget proposal, which would eliminate the cannabis cultivation tax rate beginning July 1, 2022. To go into effect, the proposal must be approved by a two-thirds majority of the state legislature by June 15, 2022. Source: [link].

Legalization 52

Legalization Collective Education Cultivation 52

Cannabis Law Report

JULY 1, 2022

Effective Friday, July, 1, 2022, the Cannabis Control Commission (Commission) has again reissued its Order Allowing for Telehealth Consultations for Patients and extended its Administrative Order Allowing Curbside Operations for Medical Marijuana Treatment Centers (MTCs) until December 31, 2022.

Patients 52

Patients Treatment Programs Access 52

Veriheal

AUGUST 11, 2023

.” Polis continued, expressing his displeasure at the fact that “in this day and age, somebody suffering from anxiety, depression, PTSD can get medical coverage for very costly prescription drugs but cannot get coverage for treatment in a healing center that will address some of the underlying causes of the issue.”

Decriminalization 65

Decriminalization Treatment Therapy Policy 65

The Cannigma

JULY 5, 2022

But it is a medical program in name only, because as of June 2022 there were no licensed dispensaries in Georgia. Despite having 20,000 registered patients in March of 2022, there are no licensed producers or distributors of cannabis products and sales are unlikely to start before mid-2023 at the earliest. Possible penalties.

Law 96

Law Decriminalization Programs Patients 96

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. The Marijuana Regulatory Agency issued a request for proposals for the 2021 Veteran Marijuana Research Grant Program on Tuesday, June 1.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

The Cannigma

JUNE 25, 2022

Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. Up until 2022, no cannabis was grown in Poland so all products had to be imported, which led to massive delays in patients being able to access medication. Is CBD legal in Poland?

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Cannabis Law Report

NOVEMBER 17, 2021

There is one problem, Malaysia currently has no registered cannabis-based treatment. In a press event, public health minister, Anutin Charnvirakul said that the ministry would promote medical cannabis to help people access treatment safely and within the law. Importers would be required to hold permits and licenses.

Research and Development 111

Research and Development Patients Treatment Pharmaceutical 111

Cannabis Law Report

APRIL 14, 2022

Before legalization, illicit grow sites did not have access to water utilities and were typically grown in arid/remote areas, often depleting local surface water and shallow aquifers not suited to intensive use. Indoor grow operations also can create a significant new demand on utility water supply infrastructure.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

JUNE 19, 2022

The Multi-organization psychedelic partnership is set to launch on June 23 2022. The Psychedelic Access and Research European Alliance (PAREA) is a group founded in 2022 and comprised of 15 organizations with common goals in the field of mental health and psychedelics. — Pain Alliance Europe (@pain_europe) June 10, 2022.

Therapy 52

Therapy Advocacy Events Treatment 52

Cannabis Law Report

APRIL 2, 2022

TORONTO, ON / ACCESSWIRE / March 31, 2022 / Novamind Inc. a leader in specialized ibogaine treatments for substance use disorder based in Sao Paolo, Brazil (the “Ibogaine Group”). a leader in specialized ibogaine treatments for substance use disorder based in Sao Paolo, Brazil (the “Ibogaine Group”).

Clinical Trials 52

Clinical Trials Research and Development Medicine Therapy 52

Cannabis Law Report

FEBRUARY 19, 2022

The AMCC anticipates that applicants may submit licenses to grow and/or manufacture medical cannabis on September 1, 2022. Under current law , the Florida Department of Health (FDOH) is responsible for overseeing the medical cannabis program, including issuing licenses to medical cannabis treatment centers.

Legalization 97

Legalization Seed-To-Sale Programs Dispensary 97

Cannabis Law Report

SEPTEMBER 7, 2022

The clinic has experienced an exceptional level of demand for medical cannabis treatments concerning anxiety and a variety of other psychiatric conditions. . Medical cannabis is a valid and legal treatment for anxiety, and we have seen great results from our patients.” . I use my prescription to treat my anxiety, ADHD+ and Autism.

Patients 52

Patients Conditions Treatment Education 52

Cannabis Law Report

FEBRUARY 9, 2022

09, 2022 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: By making psychedelic treatments cost effective, this could make treatment more widely available to patients globally. That’s a mouthful!!! VANCOUVER, British Columbia, Feb. This breakthrough in psilocybin production, can shift the entire industry.

Research and Development 52

Research and Development Clinical Trials Treatment Patients 52

Cannabis Law Report

JUNE 9, 2022

We understand the number of people who will need medical treatment due to this exposure. The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. ARV (revised).

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

AUGUST 31, 2021

Alixen™ 30 will target indications such as anxiety, insomnia, Parkinson’s Disease, and depression, while Alixen™ 100 will be used in the treatment of epilepsy. The Company also expects to have finished THC products available for commercial distribution in early 2022 to address additional pathologies, including chronic pain.

Chronic Pain 105

Chronic Pain Epilepsy THC Patients 105

Cannabis Law Report

MAY 12, 2022

May 11, 2022 02:00 AM Eastern Daylight Time. It brings access to NCEs that we can take into Phase 1 studies in the near term, coupled with access to a drug discovery pipeline that we can shape together as our experience ever deepens in the psychedelic drug development space.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

The Cannigma

DECEMBER 20, 2022

Since 2011, treatment may be offered to drug-dependent offenders as an alternative to prison only if the offender is sentenced to imprisonment for six months to two years and agrees to undergo the treatment course. There is no national cannabis program; patients can only access cannabinoid-based medications, not the plant itself.

Law 52

Law Decriminalization Cannabinoids Treatment 52

Cannabis Law Report

MAY 18, 2022

THE FIRST-EVER MEDICAL PSYCHEDELICS SERIES AT DAVOS 2022 hosted by Energia Holdings Incorporated. Thu, 19 May 2022, 3:23 am · 5-min read. A recent publication in the prominent peer-reviewed journal Nature, shows that 67% of patients no longer qualified for a PTSD diagnosis a year after treatment with MDMA (or “ecstasy”).

Research and Development 52

Research and Development Therapy Treatment Policy 52

Cannabis Law Report

MAY 26, 2022

ICPR 2022 will showcase the latest findings in psychedelic science, novel approaches in psychedelic therapy, and feature developments in policy, consciousness research, neuroscience, philosophy, and much more. Psychedelics have never been hotter,” said Joost Breeksema, the executive director of OPEN Foundation and the organiser of ICPR 2022.

Research and Development 52

Research and Development Therapy Policy Media 52